At-home STI testing program provides same-day consultation, treatment

Undergoing testing for sexually transmitted infections (STIs) can be a troubling ordeal for most people. The feeling of embarrassment can even prevent people from getting tested altogether. myLAB Box is hoping to ease the minds of patients by introducing a “Testing to Treatment” program, an at-home STI test that includes a free counseling with a physician.

The program includes the myLAB Box testing kit, giving lab-certified results in all 50 states from the comfort of their own home. If patients receive a positive result, they can connect to a local doctor for a free consultation the same day. Following the consultation, the doctor is also able to prescribe treatment at the time of the call.

Patients can order the myLAB online, test themselves wherever they want, receive their results at home and connect a local doctor who can prescribe medication through a free consultation. The complete at-home screening test eliminates the need for the patient come in for a doctor’s visit, along with the cost and travel that comes with it, and cuts the time between the visit and receiving treatment.

"The stigma of sexually transmitted infections keeps thousands of people from being tested," said Lora Ivanova, CMO and cofounder of myLAB Box. "myLAB Box aims to empower men and women to take control of their health, wherever, whenever. Our diagnostic test results are lab-certified, meaning that customers won't need a follow-up appointment to get tested 'for real.'  myLAB Box is the only complete at-home testing service available today."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.